Bank of America
ELTX icon

Bank of America’s Elicio Therapeutics ELTX Stock Holding History

Bank of America’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$164K Buy
15,333
+14,176
+1,225% +$137K ﹤0.01% 5421
2025
Q4 		$9.21K Sell
1,157
-2,428
-68% -$22K ﹤0.01% 6176
2025
Q3 		$39.2K Buy
3,585
+2,335
+187% +$23.6K ﹤0.01% 6909
2025
Q2 		$9.65K Buy
1,250
+45
+4% +$280 ﹤0.01% 7201
2025
Q1 		$7.42K Buy
1,205
+8
+0.7% +$62 ﹤0.01% 7168
2024
Q4 		$6.11K Sell
1,197
-39
-3% -$192 ﹤0.01% 7068
2024
Q3 		$6.22K Buy
1,236
+34
+3% +$151 ﹤0.01% 6972
2024
Q2 		$4.94K Buy
1,202
+56
+5% +$474 ﹤0.01% 7007
2024
Q1 		$8.71K Sell
1,146
-3
-0.3% -$15 ﹤0.01% 6907
2023
Q4 		$9.58K Sell
1,149
-532
-32% -$3.47K ﹤0.01% 6914
2023
Q3 		$14.2K Buy
1,681
+96
+6% +$914 ﹤0.01% 6783
2023
Q2 		$15.1K Sell
1,585
-1,529
-49% -$14K ﹤0.01% 6771
2023
Q1 		$18.1K Buy
3,114
+1,075
+53% +$7.17K ﹤0.01% 6782
2022
Q4 		$16.5K Sell
2,039
-989
-33% -$8.99K ﹤0.01% 6791
2022
Q3 		$28K Sell
3,028
-1,422
-32% -$14.9K ﹤0.01% 6898
2022
Q2 		$50K Sell
4,450
-1,894
-30% -$30.2K ﹤0.01% 6827
2022
Q1 		$134K Sell
6,344
-377
-6% -$8.51K ﹤0.01% 6706
2021
Q4 		$195K Buy
6,721
+3,785
+129% +$191K ﹤0.01% 6510
2021
Q3 		$287K Buy
2,936
+2,025
+222% +$219K ﹤0.01% 6035
2021
Q2 		$119K Sell
911
-862
-49% -$124K ﹤0.01% 6423
2021
Q1 		$320K Buy
+1,773
New +$342K ﹤0.01% 5707

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America's ELTX Position: Q1 2026 in Review

Bank of America increased its Elicio Therapeutics (ELTX) stake by 1,225% in Q1 2026, buying an estimated $137K and bringing the position to 15,333 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #5421.

Bank of America first reported a position in ELTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $320K in Q1 2021. 47 funds tracked by Wall St. Rank hold ELTX as of Q1 2026.

  • Bank of America held 15,333 shares of Elicio Therapeutics worth $164K as of Q1 2026.
  • Bank of America bought 14,176 Elicio Therapeutics shares in Q1 2026, an estimated $137K.
  • Elicio Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5421 holding.
  • Bank of America first reported a position in Elicio Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Bank of America's Elicio Therapeutics position peaked at $320K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.